Related Experiment Video
Updated: Aug 6, 2026

Models of Bone Metastasis
Published on: September 4, 2012
[Molecular targets for the treatment of bone metastases]
1Department of Biochemistry, Osaka University Graduate School of Dentistry.
Abstract:
Bone is one of the most common sites of cancer metastases. Bone metastases cause devastating complications including intractable bone pain, pathologic fractures and hypercalcemia, and profoundly harm the quality of life of the patients. Therefore, intervention of bone metastases is critical for the management of cancer patients and improvement of their outcome. Nevertheless, cancer cells colonizing in bone are essentially uncontrollable with currently available therapies. In this review, the molecular targets for the treatment of bone metastases are discussed.
Related Concept Videos
Drugs that Stabilize Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

